Рет қаралды 14,090
Robert Rees answers questions on cancer stem cells and successful and potential treatments, including antibody therapy and vaccine based immunotherapy.
ukcatalogue.oup...
Tumor Immunology and Immunotherapy is edited by Dr Robert C. Rees, Director and Professor of Tumour Biology, The John van Geest Cancer Research Centre, Nottingham Trent University, UK. Robert is the head of a team researching prostate and breast cancer vaccine therapies. He has published extensively in the field of tumour immunology and has previously worked at The Universities of Sheffield and Nottingham and at The National Institutes of Health, Bethesda, USA. His laboratory has discovered several tumour antigens as immunotherapy targets and established many of these as biomarkers, associating with disease status. Robert has edited 3 other books on cancer immunity and he is an Editor for the journal Cancer Immunology and Immunotherapy, amongst other journals.
© Oxford University Press